KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in ReceivablesChange in Working CapitalDeferred TaxesExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurora Cannabis (ACB) Asset Writedowns and Impairment: 2019-2022

Historic Asset Writedowns and Impairment for Aurora Cannabis (ACB) over the last 2 years, with Jun 2022 value amounting to -$261.6 million.

  • Aurora Cannabis' Asset Writedowns and Impairment was N/A to -$261.6 million in Q2 2022 from the same period last year, while for Jun 2022 it was -$241.3 million, marking a year-over-year change of. This contributed to the annual value of -$4.3 million for FY2022, which is 101.01% down from last year.
  • As of Q2 2022, Aurora Cannabis' Asset Writedowns and Impairment stood at -$261.6 million, which was down 5,947.98% from -$4.3 million recorded in Q1 2022.
  • In the past 5 years, Aurora Cannabis' Asset Writedowns and Impairment registered a high of $179.6 million during Q4 2020, and its lowest value of -$261.6 million during Q2 2022.
  • Moreover, its 3-year median value for Asset Writedowns and Impairment was -$4.1 million (2021), whereas its average is -$7.4 million.
  • In the last 5 years, Aurora Cannabis' Asset Writedowns and Impairment skyrocketed by 428.80% in 2021 and then tumbled by 106.26% in 2022.
  • Over the past 4 years, Aurora Cannabis' Asset Writedowns and Impairment (Quarterly) stood at $70.0 million in 2019, then spiked by 156.44% to $179.6 million in 2020, then crashed by 84.17% to $28.4 million in 2021, then tumbled by 106.26% to -$261.6 million in 2022.
  • Its Asset Writedowns and Impairment was -$261.6 million in Q2 2022, compared to -$4.3 million in Q1 2022 and $28.4 million in Q4 2021.